+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tetrabenazine"

From
From
From
Huntington's Disease Treatment Market Report 2026 - Product Thumbnail Image

Huntington's Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Neurodegenerative Disorder Therapeutics Market Report 2026 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Huntington's Disease Market Report 2026 - Product Thumbnail Image

Huntington's Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Tardive Dyskinesia Treatment Market Report 2026 - Product Thumbnail Image

Tardive Dyskinesia Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Huntington's Disease: Opportunity Assessment and Forecast - Product Thumbnail Image

Huntington's Disease: Opportunity Assessment and Forecast

  • Report
  • October 2025
  • 84 Pages
  • Global
From
From
United States Huntington's Disease Treatment Market Forecast 2025-2033 - Product Thumbnail Image

United States Huntington's Disease Treatment Market Forecast 2025-2033

  • Report
  • July 2025
  • 200 Pages
  • United States
From
Tourette Syndrome Treatment Market - Product Thumbnail Image

Tourette Syndrome Treatment Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
United States AUSTEDO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States AUSTEDO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
Huntington's Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Huntington's Disease Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Huntington's Disease Treatment Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Huntington's Disease Treatment Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 145 Pages
  • Global
From
Loading Indicator

Tetrabenazine is a drug used to treat musculoskeletal disorders, such as Huntington's disease, tardive dyskinesia, and chorea. It works by blocking the action of dopamine, a neurotransmitter that plays a role in movement control. Tetrabenazine is available in both oral and injectable forms. It is typically used in combination with other medications to reduce the severity of symptoms. Tetrabenazine is a relatively new drug, and its use in the treatment of musculoskeletal disorders is still being studied. It is believed to be effective in reducing the severity of symptoms, but its long-term safety and efficacy are still being evaluated. The tetrabenazine market is growing as more people are being diagnosed with musculoskeletal disorders. The drug is becoming increasingly popular as a treatment option for these conditions. Some companies in the tetrabenazine market include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. These companies produce and distribute tetrabenazine in various forms, including tablets, capsules, and injections. Show Less Read more